Type IIb CSU, a well-defined subgroup characterized by low total IgE levels and elevated IgG anti-TPO antibodies, predominantly affects women and is characterized by late disease onset, high disease activity, frequent angioedema, and a higher prevalence of autoimmune comorbidities (5, 7). This evidence concerns the gene IGHE and angioedema.